UK markets open in 5 hours 44 minutes

Corcept Therapeutics Incorporated (0I3Q.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
31.54+0.56 (+1.81%)
At close: 07:08PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 314.89%
S&P500 52-week change 324.16%
52-week high 334.12
52-week low 30.00
50-day moving average 323.44
200-day moving average 326.00

Share statistics

Avg vol (3-month) 32.32k
Avg vol (10-day) 3705
Shares outstanding 5115.47M
Implied shares outstanding 6N/A
Float 885M
% held by insiders 111.39%
% held by institutions 192.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.54%
Operating margin (ttm)20.09%

Management effectiveness

Return on assets (ttm)11.96%
Return on equity (ttm)21.91%

Income statement

Revenue (ttm)523.53M
Revenue per share (ttm)5.12
Quarterly revenue growth (yoy)39.00%
Gross profit (ttm)N/A
EBITDA 122.8M
Net income avi to common (ttm)117.2M
Diluted EPS (ttm)0.91
Quarterly earnings growth (yoy)74.80%

Balance sheet

Total cash (mrq)410.76M
Total cash per share (mrq)3.94
Total debt (mrq)76k
Total debt/equity (mrq)0.01%
Current ratio (mrq)5.18
Book value per share (mrq)5.27

Cash flow statement

Operating cash flow (ttm)124.84M
Levered free cash flow (ttm)123.86M